AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

029 Group SE

M&A Activity Apr 26, 2012

4544_rns_2012-04-26_3db2f982-c8f6-417e-a370-d8b98b6edbd6.html

M&A Activity

Open in Viewer

Opens in native device viewer

News Details

Takeover Bids | 26 April 2012 08:51

Takeover Offer;

Target company: RHÖN-KLINIKUM Aktiengesellschaft; Bidder: FPS Beteiligungs AG

Dissemination of an announcement according to the German Securities

Acquisition and Takeover Act (WpÜG), transmitted by DGAP – a company of

EquityStory AG.

The bidder is solely responsible for the content of this announcement.

—————————————————————————

Announcement of the Decision to make a Public Takeover Offer (öffentliches

Übernahmeangebot) pursuant to Section 10 para. 1 in conjunction with

Sections 29, 34 of the German Securities Acquisition and Takeover Act

(Wertpapiererwerbs- und Übernahmegesetz – ‘WpÜG’)

Bidder:

FPS Beteiligungs AG

Borkenberg 14

61440 Oberursel

Germany

registered in the commercial register of the local court (Amtsgericht) of

Düsseldorf under HRB 67801

Target:

RHÖN-KLINIKUM Aktiengesellschaft

Schlossplatz 1

97616 Neustadt a.d. Saale

Germany

registered in the commercial register of the local court (Amtsgericht) of

Schweinfurt under HRB 1670

ISIN: DE0007042301 (WKN: 704 230)

On 26 April 2012, FPS Beteiligungs AG decided to make a voluntary public

takeover offer to the shareholders of RHÖN-KLINIKUM Aktiengesellschaft to

acquire their bearer shares in RHÖN-KLINIKUM Aktiengesellschaft with no par

value, each representing a pro-rata amount of the share capital of EUR 2.50

(the ‘RHÖN-KLINIKUM-Shares’), against payment of a cash consideration of

EUR 22.50 per RHÖN-KLINIKUM-Share (the ‘Takeover Offer’).

The offer document and further information relating to the Takeover Offer

will be published on the internet at www.fresenius.de.

Further Information:

FPS Beteiligungs AG is an indirect subsidiary of Fresenius SE & Co. KGaA.

The Takeover Offer will be made only subject to the clearance by the cartel

authorities and a minimum participation quota of 90 % + 1 share. The

shareholders Eugen and Ingeborg Münch undertook vis-à-vis FPS Beteiligungs

AG to accept within the acceptance period the Takeover Offer with regard to

their shares representing 12.45 % of the share capital of RHÖN-KLINIKUM

Aktiengesellschaft.

Apart from this, the offer will be made on and subject to the terms and

conditions to be set out in the offer document.

Important Notice:

This announcement is neither an offer to purchase nor a solicitation of an

offer to sell shares of RHÖN-KLINIKUM Aktiengesellschaft. The definite

terms and conditions of the Takeover Offer, as well as further provisions

concerning the Takeover Offer, will be published in the offer document only

after the German Federal Financial Supervisory Authority has granted

permission to publish the offer document. Investors and holders of shares

in RHÖN-KLINIKUM Aktiengesellschaft are strongly advised to read the offer

document and all other relevant documents regarding the Takeover Offer when

they become available, since they will contain important information.

Oberursel, 26 April 2012

FPS Beteiligungs AG

———————

Listed: Regulated Market (Regulierter Markt) in Frankfurt (Prime Standard)

and Munich, unofficial dealings (Freiverkehr) in Berlin, Düsseldorf,

Hamburg, Hanover and Stuttgart

End of WpÜG announcement

26.04.2012DGAP’s Distribution Services include Regulatory Announcements,

Financial/Corporate News and Press Releases.

Media archive at www.dgap-medientreff.de and www.dgap.de

—————————————————————————

Listed: Regulierter Markt in Frankfurt (Prime Standard) und München;

Freiverkehr in Berlin, Düsseldorf, Hamburg, Hannover und Stuttgart

Talk to a Data Expert

Have a question? We'll get back to you promptly.